Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Security

FLACW · Frazier Lifesciences Acquisition Corp

FLACWNASDAQWarrantHistorical · closed Nov 22, 2022CIK 1828326Updated Sep 30, 2026

Company: Frazier Lifesciences Acquisition Corp →

FLACW price & chart

Provider market data
Historical security

This listing closed Nov 22, 2022. Live provider charts are shown only for current listings.

In the news

No coverage from other publishers is available.

Recent filings

  1. 15-12G filing

    15-12G · 2022-12-02 · 0001193125-22-297570

  2. 8-K filing

    8-K · 2022-11-23 · 0001193125-22-292061

  3. 4 filing

    4 · 2022-11-23 · 0000899243-22-036936

  4. 4 filing

    4 · 2022-11-23 · 0000899243-22-036925

  5. SC 13D/A filing

    SC 13D/A · 2022-11-23 · 0001193125-22-292025

Show 5 more recent filings

  1. 25-NSE filing

    25-NSE · 2022-11-22 · 0001354457-22-000662

  2. 25-NSE filing

    25-NSE · 2022-11-22 · 0001354457-22-000661

  3. 25-NSE filing

    25-NSE · 2022-11-22 · 0001354457-22-000660

  4. 8-K filing

    8-K · 2022-11-15 · 0001193125-22-285506

  5. 10-Q filing

    10-Q · 2022-11-09 · 0001193125-22-281196

Financials

FY 2021 · USD
Revenue— · FY 2021
Net income— · FY 2021
Operating income— · FY 2021
Diluted EPS— · FY 2021

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2021FY 2020
ASSETS
AssetsUSD139,505,058
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

139,869,628
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD1,226,716
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

1,365,094
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

Assets, CurrentUSD1,488,049
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

1,868,777
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD7,864,604
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

12,407,701
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

Stockholders’ equity:
Additional Paid in CapitalUSD0
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

0
Source

10-Q · 2021-11-09 · 0001193125-21-324421

As of 2020-12-31

Retained Earnings (Accumulated Deficit)USD-6,359,941
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

-10,538,468
Source

10-Q · 2021-11-09 · 0001193125-21-324421

As of 2020-12-31

Stockholders' Equity Attributable to ParentUSD-6,359,546
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

-10,538,073
Source

10-Q · 2021-11-09 · 0001193125-21-324421

As of 2020-12-31

Liabilities and EquityUSD139,505,058
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

139,869,628
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

Current liabilities:
Liabilities, CurrentUSD222,074
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

236,521
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

Accounts Payable, CurrentUSD167,324
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

162,478
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD54,750
Source

10-K · 2022-03-25 · 0001193125-22-085304

As of 2021-12-31

74,043
Source

10-Q · 2021-05-24 · 0001193125-21-171117

As of 2020-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2021
Cash flows from operating activities:
Net Cash Provided by (Used in) Operating ActivitiesUSD-138,378
Source

10-K · 2022-03-25 · 0001193125-22-085304

2021-01-01 to 2021-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD0
Source

10-K · 2022-03-25 · 0001193125-22-085304

2021-01-01 to 2021-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD0
Source

10-K · 2022-03-25 · 0001193125-22-085304

2021-01-01 to 2021-12-31

Additional Financial Items
General and Administrative ExpenseUSD1,246,281
Source

10-K · 2022-03-25 · 0001193125-22-085304

2021-01-01 to 2021-12-31

Investment Income, InterestUSD16,158
Source

10-K · 2022-03-25 · 0001193125-22-085304

2021-01-01 to 2021-12-31

Net Income (Loss) Attributable to ParentUSD4,178,527
Source

10-K · 2022-03-25 · 0001193125-22-085304

2021-01-01 to 2021-12-31

Unrealized Gain (Loss) on InvestmentsUSD16,158
Source

10-K · 2022-03-25 · 0001193125-22-085304

2021-01-01 to 2021-12-31

Lines labelled “Derived” are calculated from reported figures.